Celator Pharmaceuticals' Series E Round

Celator Pharmaceuticals raised a round of funding on December 28, 2011.

Celator Pharmaceuticals is a pharmaceutical company developing new and effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents an approach that identif…

Articles about Celator Pharmaceuticals' Series E Round: